Bristol-Myers Squibb Company (BMY) Bristol Myers Squibb Reinforces Leadership in oHCM with New Camzyos (mavacamten) Data at American College of Cardiology Annual Scientific Session & Expo 2026 (ACC.26)

Bristol-Myers Squibb Company (NYSE: BMY) FY 2026 Other Release

Newsdesk: